United States· US:72572-232_a6cac857-b1a1-4c77-95bb-1a142f6b68c5
Potassium Phosphates
A medicinal product containing monobasic potassium phosphate; dibasic potassium phosphate, registered in United States by CIVICA, INC..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- MONOBASIC POTASSIUM PHOSPHATE; DIBASIC POTASSIUM PHOSPHATE
- Manufacturer
- CIVICA, INC.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc1172572-232-25
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Monobasic potassium phosphate; dibasic potassium phosphate in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaPOTASSIUM PHOSPHATESSANDOZ CANADA INCORPORATED
- GermanyKaliumphosphat B. BraunB.Braun Melsungen Ag
- IrelandPotassium Phosphate 1mmol/ml + 0.6mmol/ml Concentrate for Solution for InfusionB. Braun Medical Limited
- NorwayPotassio fosfato galenica seneseIndustria Farmaceutica Galenica Senese
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Belgium · Kaliphos, Kaliumfosfaat B. Braun
- Germany · Kaliumphosphat B. Braun
- Ireland · Potassium Phosphate B Braun Medical
- Italy · Potassio Fosfato Bioindustria L.I.M., Potassio Fosfato Galenica Senese
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0bf1bf68-69b1-43c6-8f9b-e6aa636a7f2f GET /v1/drugs/0bf1bf68-69b1-43c6-8f9b-e6aa636a7f2f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "224; 236",
"substance": "MONOBASIC POTASSIUM PHOSPHATE; DIBASIC POTASSIUM PHOSPHATE",
"productndc": "72572-232",
"dosage_form": "INJECTION, SOLUTION, CONCENTRATE",
"dea_schedule": null,
"strength_unit": "mg/mL; mg/mL",
"application_number": "NDA212832",
"marketing_category": "NDA"
}See everything about monobasic potassium phosphate; dibasic potassium phosphate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.